Global and China Fc Fusion Protein Market Insights, Forecast to 2027
- September 2021
- 141 pages
Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structurefunction properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins
This report will focus on Fc fusion protein drugs.
Global Fc Fusion Protein market key players include Sanofi, Sobi, Eli Lilly and Company, etc., and the top 3 players hold about 70% of global shares. North America and Europe are main markets, they occupy about 90% of the global market. Brands drugs is the key type, with a share over 90%. Autoimmune disease and eye diseases are two main applications, they have over 60% shares altogther.
Market Analysis and Insights: Global and China Fc Fusion Protein Market
This report focuses on global and China Fc Fusion Protein market.
In 2020, the global Fc Fusion Protein market size was US$ 27020 million and it is expected to reach US$ 54290 million by the end of 2027, with a CAGR of 10.7% during 2021-2027. In China the Fc Fusion Protein market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Fc Fusion Protein Scope and Market Size
Fc Fusion Protein market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Fc Fusion Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Fc Fusion Protein market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Segment by Application
Middle East & Africa
Eli Lilly and Company
Product Type & Applications
- Bristol-Myers Squibb
- Eli Lilly and Company
- Kanghong Pharma
- Celgen Biopharma
- Fc Fusion Protein
- Autoimmune Disease
- Eye Diseases
Have query on this report?Make an Enquiry
1.1 Fc Fusion Protein Product Introduction
1.2 Market by Type
1.2.1 Global Fc Fusion Protein Market Size Growth Rate by Type
1.2.2 Brands Drugs
Table 1. Global Fc Fusion Protein Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Brands Drugs
Table 3. Major Manufacturers of Biosimilar Drugs
Table 4. Global Fc Fusion Protein Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Fc Fusion Protein Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017